Is the DEA's new prescription series regulation balanced?

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 22, Issue 3, 2008, Pages 218-220

  Gilson, Aaron M ^a,c   Joranson, David E ^b  

^a US Program   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c Pain and Policy Studies Group   (United States)

Author keywords

Balance; Controlled substances; DEA; Diversion; Drug Enforcement Administration; Drug regulation; Prescription series; Prescriptions

Indexed keywords

CONTROLLED SUBSTANCE; DRUG; NARCOTIC ANALGESIC AGENT; UNCLASSIFIED DRUG; PRESCRIPTION DRUG;

ANALGESIC AGENT ABUSE; DRUG ABUSE; DRUG CLASSIFICATION; GOVERNMENT; HUMAN; LAW ENFORCEMENT; NOTE; ORGANIZATION; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PHYSICIAN; POLICY; PRESCRIPTION; PRESCRIPTIVE AUTHORITY; PROFESSIONAL PRACTICE; UNITED STATES; ADDICTION; ARTICLE; CLINICAL PRACTICE; DRUG CONTROL; LEGAL ASPECT;

DRUG AND NARCOTIC CONTROL; DRUG PRESCRIPTIONS; GOVERNMENT AGENCIES; HUMANS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 60249092530     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1080/15360280802251223     Document Type: Note

References (7)

1. Drug Enforcement Administration. Issuance of multiple prescriptions for Schedule II controlled substances. Federal Register 2007;72(222):64921-64930.
2. Drug Enforcement Administration. Issuance of multiple prescriptions for Schedule II controlled substances. Federal Register 2006;71(172):52724-52726.
3. Drug Enforcement Administration. Issuance of multiple prescriptions for Schedule II controlled substances. Federal Register 2006;71(172):52715-52723.
4. Drug Enforcement Administration. Clarification of existing requirements under the Controlled Substances Act for prescribing Schedule II controlled substances. Federal Register 2005;70(165):50408-50409.
5. Drug Enforcement Administration. Solicitation of commentson dispensing ofcontrolled substances for the treatment of pain. Federal Register 2005;70(11):2883-2884.
6. Gilson AM, Joranson DE. The Federal Drug Enforcement Administration "prescription series" proposal: continuing concerns. J Pain Palliat Care Pharmacother 2007;21:21-24.
7. Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation (Fourth edition). Madison, WI: University of Wisconsin Paul P. Carbone Comprehensive Cancer Center; 2007.